Kim MS, Kim JS, Park H, Chung Y, Kim H, Ko DH, Hwang SH, Won HS, Oh HB. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
a antibody: A case report and literature review.
Transfus Apher Sci 2019;
59:102605. [PMID:
31324575 DOI:
10.1016/j.transci.2019.06.029]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2019] [Revised: 04/01/2019] [Accepted: 06/03/2019] [Indexed: 10/26/2022]
Abstract
The Jra antigen of the JR blood group system is a highly prevalent red blood cell antigen. Although anti-Jra-associated hemolytic disease of the fetus and newborn (HDFN) is generally considered mild-to-moderate, a rare fatal case was recently reported. We report the third example of HDFN-related anti-Jra with fatal outcomes. The clinical significance of anti-Jra antibody as a cause of HDFN should be reassessed.
Collapse